We’re delighted to announce that Guilhem Tourniaire has joined Bionomous as Chief Business Officer.
Guilhem brings more than a decade of leadership in life sciences instrumentation and lab automation. He is the founder of Cellenion, the single-cell isolation and dispensing company he built and led for ten years, first as Founder and Scientific Director and then as Managing Director. Before that, he drove business development for France at Scienion AG, a specialist in microarray and dispensing technologies. He holds a PhD in High-Throughput Chemical Biology from the University of Edinburgh, with doctoral work on cell-based polymer microarrays.
As CBO, Guilhem will lead our commercial strategy, partnerships, and growth as we scale Sortivo and expand into new applications across organoids, and spheroids. His experience turning advanced automation technology into a successful business is exactly what we need at this stage, as demand for our platforms grows across academia, core facilities, and industry.
Please join us in giving Guilhem a warm welcome to the team. We’re excited about what’s ahead.